Abacavir and Gallbladder attack - a phase IV clinical study of FDA data

Summary:

Gallbladder attack is reported as a side effect among people who take Abacavir (abacavir sulfate), especially for people who are male, 40-49 old, also take Daklinza, and have Hepatitis c.

The phase IV clinical study analyzes which people have Gallbladder attack when taking Abacavir. It is created by eHealthMe based on reports of 8,281 people who have side effects when taking Abacavir from the FDA, and is updated regularly.

What is Abacavir?

Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.

What is Gallbladder attack?

Gallbladder attack (gallstones, gallbladder disease and gallbladder pain) is found to be associated with 650 drugs and 978 conditions by eHealthMe. Check the latest studies of Gallbladder attack.

On Jan, 14, 2026

8,281 people reported to have side effects when taking Abacavir.
Among them, 9 people (0.11%) have Gallbladder attack.

Could Abacavir cause Gallbladder attack?

Among these 9 people:

What is the gender of people who have Gallbladder attack when taking Abacavir? *

female: 0.0 %
male: 100 %

What is the age of people who have Gallbladder attack when taking Abacavir? *

What are other drugs people take besides Abacavir? *

What are other side effects people have besides Gallbladder attack? *

Hyperbilirubinaemia (excess of bilirubin in the blood): 9 people, 100.00%
Kidney Stones: 8 people, 88.89%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 8 people, 88.89%
Haemoglobin Decreased: 8 people, 88.89%
Gallstones (stone formation by bile component): 8 people, 88.89%
Anaemia (lack of blood): 7 people, 77.78%
Renal Tubular Disorder (disease of kidney tubules): 6 people, 66.67%
Renal Disorder (kidney disease): 6 people, 66.67%
Haemolytic Anaemia (anaemia due to haemolysis): 5 people, 55.56%
Interstitial Nephritis (inflammation of the kidney): 4 people, 44.44%

What are the existing conditions these people have? *

Hepatitis C: 9 people, 100.00%
Nausea (feeling of having an urge to vomit): 8 people, 88.89%
Indigestion: 8 people, 88.89%
Anaemia (lack of blood): 8 people, 88.89%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 5 people, 55.56%
Chronic Hepatitis (long lasting inflammation of liver): 4 people, 44.44%
Drug Dependence: 3 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Abacavir and have Gallbladder attack?

- Check whether Gallbladder attack is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abacavir:

Abacavir (8,306 reports)

Browse all side effects of Abacavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gallbladder attack:

Gallbladder attack (650 drugs)

Browse all the conditions that are associated with Gallbladder attack:

Gallbladder attack (978 conditions)

Drugs similar to Abacavir and Gallbladder attack :

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Abacavir) and Abacavir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.